Lung Immune Therapy Evaluation (LITE) Risk, a Novel Prognostic Model for Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Blockade
- Resource Type
- Source
- Clinical Lung Cancer. 24:e152-e159
- Subject
Pulmonary and Respiratory Medicine Cancer Research Oncology - Language
- ISSN
- 1525-7304